RecallDepth
Class II Terminated

Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/12.5 mg, Rx only, 7 tablets per bottle, Physician Sample - Not For Sale. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9559-89

Company
Novartis Pharmaceuticals Corp.
Recall Initiated
August 8, 2013
Posted
December 18, 2013
Recall Number
D-331-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
328,543 bottles
Firm Location
Suffern, NY, United States

Reason for Recall

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Product code: 715523 & 725278; Lot Number: F0019, F0019A, Exp 08/31/2013; F0020, Exp 09/30/2013; F0021, F0021A, Exp 10/31/2013; F0022, F0025, Exp 11/30/2013; F0024, F0026, Exp 12/31/2013; F0027, Exp 09/30/2014

More recalls by Novartis Pharmaceuticals Corp.

View all recalls by this company →

Other recent Class II Drug recalls